Thesan Pharmaceuticals, Inc.
Industry
- Biotechnology
- Pharmaceuticals
- Drug Delivery
- Topical Delivery
- Drug Delivery
Latest on Thesan Pharmaceuticals, Inc.
Start-Up Execs Agilis Biotherapeutics LLC Mark Pykett, PhD To: Pres. & CEO (September) From: Pres. & CEO, Navidea Biopharmaceuticals Inc. Phone: 214-706-4340 Aurora Spine Corp. Mike Wheeloc
IN VITRO DIAGNOSTICS HTG Molecular Diagnostics Inc. HTG Molecular Diagnostics raises $21.7mm Series E round HTG Molecular Diagnostics Inc. (molecular chemistry platforms for RNA analysis) rais
Financings In the fourth quarter of 2012, start-up companies raised a total of $670.3 million across all industries, which was just $11.6 million less than in Q3. ( See Exhibit 1. ) Biopharmas brought
Financings Biopharma financing in the final quarter of 2012 reached $4.2 billion, a 36% increase over Q3’s $3.1 billion, again boosted by a strong showing from follow-on public offerings. The fourth q